Business classification

VCID: 281769
    Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Metsera Inc
    Developer of medicines for obesity and metabolic diseases.
    United States 13 Nov 2024 Series B
    Initial investment. Round participant. Active
    Ajax Therapeutics Inc
    Blood cancer biotech.
    United States 13 May 2024 Series C
    Initial investment. Round participant. Active
    Mitra Biotech Pvt Ltd
    Developer of personalized cancer treatments.
    India 29 Aug 2016 Series B
    Initial investment. Round participant. Active
    Synthorx Inc
    United States N/A
    Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.